In particular, since inhibition of NF-κB activation is a key issue in tumor resistance against ionizing radiation (IR) in CRC cells [13], NF-κB is a promising target for the improvement of radiosensivity in patients with CRC. Here, NFKB1 is linked to colorectal carcinoma.